1
|
Lázaro-Gorines R, López-Rodríguez JC, Benedé S, González M, Mayorga C, Vogel L, Martínez-Del-Pozo Á, Lacadena J, Villalba M. Der p 1-based immunotoxin as potential tool for the treatment of dust mite respiratory allergy. Sci Rep 2020; 10:12255. [PMID: 32703972 PMCID: PMC7378242 DOI: 10.1038/s41598-020-69166-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2020] [Accepted: 06/04/2020] [Indexed: 11/25/2022] Open
Abstract
Immunotoxins appear as promising therapeutic molecules, alternative to allergen-specific-immunotherapy. In this work, we achieved the development of a protein chimera able to promote specific cell death on effector cells involved in the allergic reaction. Der p 1 allergen was chosen as cell-targeting domain and the powerful ribotoxin α-sarcin as the toxic moiety. The resultant construction, named proDerp1αS, was produced and purified from the yeast Pichia pastoris. Der p 1-protease activity and α-sarcin ribonucleolytic action were effectively conserved in proDerp1αS. Immunotoxin impact was assayed by using effector cells sensitized with house dust mite-allergic sera. Cell degranulation and death, triggered by proDerp1αS, was exclusively observed on Der p 1 sera sensitized-humRBL-2H3 cells, but not when treated with non-allergic sera. Most notably, equivalent IgE-binding and degranulation were observed with both proDerp1αS construct and native Der p 1 when using purified basophils from sensitized patients. However, proDerp1αS did not cause any cytotoxic effect on these cells, apparently due to its lack of internalization after their surface IgE-binding, showing the complex in vivo panorama governing allergic reactions. In conclusion, herein we present proDerp1αS as a proof of concept for a potential and alternative new designs of therapeutic tools for allergies. Development of new, and more specific, second-generation of immunotoxins following proDerp1αS, is further discussed.
Collapse
Affiliation(s)
- Rodrigo Lázaro-Gorines
- Biochemistry and Molecular Biology Department, Chemical Sciences Faculty, Complutense University of Madrid, Av. Complutense w/n, 28040, Madrid, Spain
| | - Juan Carlos López-Rodríguez
- Biochemistry and Molecular Biology Department, Chemical Sciences Faculty, Complutense University of Madrid, Av. Complutense w/n, 28040, Madrid, Spain
| | - Sara Benedé
- Biochemistry and Molecular Biology Department, Chemical Sciences Faculty, Complutense University of Madrid, Av. Complutense w/n, 28040, Madrid, Spain
| | - Miguel González
- Allergy Research Laboratory, IBIMA, Hospital Regional Universitario de Málaga, UMA, Málaga, Spain
| | - Cristobalina Mayorga
- Allergy Research Laboratory, IBIMA, Hospital Regional Universitario de Málaga, UMA, Málaga, Spain.,U.G.C. Allergy, IBIMA, Hospital Regional Universitario de Málaga, UMA, Málaga, Spain
| | - Lothar Vogel
- Division of Allergology, Paul-Ehrlich-Institut, Langen, Germany
| | - Álvaro Martínez-Del-Pozo
- Biochemistry and Molecular Biology Department, Chemical Sciences Faculty, Complutense University of Madrid, Av. Complutense w/n, 28040, Madrid, Spain
| | - Javier Lacadena
- Biochemistry and Molecular Biology Department, Chemical Sciences Faculty, Complutense University of Madrid, Av. Complutense w/n, 28040, Madrid, Spain.
| | - Mayte Villalba
- Biochemistry and Molecular Biology Department, Chemical Sciences Faculty, Complutense University of Madrid, Av. Complutense w/n, 28040, Madrid, Spain.
| |
Collapse
|
2
|
Soh WT, Aglas L, Mueller GA, Gilles S, Weiss R, Scheiblhofer S, Huber S, Scheidt T, Thompson PM, Briza P, London RE, Traidl‐Hoffmann C, Cabrele C, Brandstetter H, Ferreira F. Multiple roles of Bet v 1 ligands in allergen stabilization and modulation of endosomal protease activity. Allergy 2019; 74:2382-2393. [PMID: 31230350 PMCID: PMC6910946 DOI: 10.1111/all.13948] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2019] [Accepted: 04/30/2019] [Indexed: 12/21/2022]
Abstract
Background Over 100 million people worldwide suffer from birch pollen allergy. Bet v 1 has been identified as the major birch pollen allergen. However, the molecular mechanisms of birch allergic sensitization, including the roles of Bet v 1 and other components of the birch pollen extract, remain incompletely understood. Here, we examined how known birch pollen–derived molecules influence the endolysosomal processing of Bet v 1, thereby shaping its allergenicity. Methods We analyzed the biochemical and immunological interaction of ligands with Bet v 1. We then investigated the proteolytic processing of Bet v 1 by endosomal extracts in the presence and absence of ligands, followed by a detailed kinetic analysis of Bet v 1 processing by individual endolysosomal proteases as well as the T‐cell epitope presentation in BMDCs. Results We identified E1 phytoprostanes as novel Bet v 1 ligands. Pollen‐derived ligands enhanced the proteolytic resistance of Bet v 1, affecting degradation kinetics and preferential cleavage sites of the endolysosomal proteases cathepsin S and legumain. E1 phytoprostanes exhibited a dual role by stabilizing Bet v 1 and inhibiting cathepsin protease activity. Conclusion Bet v 1 can serve as a transporter of pollen‐derived, bioactive compounds. When carried to the endolysosome, such compounds can modulate the proteolytic activity, including its processing by cysteine cathepsins. We unveil a paradigm shift from an allergen‐centered view to a more systemic view that includes the host endolysosomal enzymes.
Collapse
Affiliation(s)
- Wai Tuck Soh
- Department of Biosciences University of Salzburg Salzburg Austria
| | - Lorenz Aglas
- Department of Biosciences University of Salzburg Salzburg Austria
| | - Geoffrey A. Mueller
- Department of Health and Human Services, Genome Integrity and Structural Biology Laboratory National Institute of Environmental Health Sciences, National Institutes of Health Research Triangle Park North Carolina
| | - Stefanie Gilles
- Institute of Environmental Medicine UNIKA‐T, Technical University Munich and Helmholtz Zentrum München Augsburg Germany
- Christine‐Kühne‐Center for Allergy Research and Education (CK CARE) Davos Switzerland
| | - Richard Weiss
- Department of Biosciences University of Salzburg Salzburg Austria
| | | | - Sara Huber
- Department of Biosciences University of Salzburg Salzburg Austria
| | - Tamara Scheidt
- Department of Biosciences University of Salzburg Salzburg Austria
| | - Peter M. Thompson
- Department of Health and Human Services, Genome Integrity and Structural Biology Laboratory National Institute of Environmental Health Sciences, National Institutes of Health Research Triangle Park North Carolina
| | - Peter Briza
- Department of Biosciences University of Salzburg Salzburg Austria
| | - Robert E. London
- Department of Health and Human Services, Genome Integrity and Structural Biology Laboratory National Institute of Environmental Health Sciences, National Institutes of Health Research Triangle Park North Carolina
| | - Claudia Traidl‐Hoffmann
- Institute of Environmental Medicine UNIKA‐T, Technical University Munich and Helmholtz Zentrum München Augsburg Germany
- Christine‐Kühne‐Center for Allergy Research and Education (CK CARE) Davos Switzerland
| | - Chiara Cabrele
- Department of Biosciences University of Salzburg Salzburg Austria
| | | | - Fatima Ferreira
- Department of Biosciences University of Salzburg Salzburg Austria
| |
Collapse
|
3
|
Fonseca DM, Wowk PF, Paula MO, Gembre AF, Baruffi MD, Fermino ML, Turato WM, Campos LW, Silva CL, Ramos SG, Horn C, Marchal G, Arruda LK, Russo M, Bonato VLD. Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy. Allergy 2015; 70:275-84. [PMID: 25477068 DOI: 10.1111/all.12555] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/02/2014] [Indexed: 01/01/2023]
Abstract
BACKGROUND We have shown that mycobacterial antigens and CpG oligodeoxynucleotides downmodulate airway allergic inflammation by mechanisms dependent on T-cell activation. Here, we investigated the participation of the innate response, particularly the role of MyD88 adaptor, and Fas molecules in the effectiveness of DNA-HSP65 or CpG/culture filtrated proteins (CFP) immunotherapy. METHODS Mice sensitized and challenged with Der p 1 allergen were treated with DNA-HSP65, CpG/CFP, or with adoptively transferred cells from immunized mice. The treatment efficacy was assessed by evaluating eosinophil recruitment, antibody, and cytokine production. RESULTS In addition to downregulating the Th2 response, DNA-HSP65 and CpG/CFP promoted IL-10 and IFN-γ production. Adoptive transfer of cells from mice immunized with DNA-HSP65 or CpG/CFP to allergic recipients downmodulated the allergic response. Notably, transfer of cells from DNA-HSP65- or CpG/CFP-immunized MyD88(-/-) mice failed to reduce allergy. Additionally, for effective reduction of allergy by cells from CpG/CFP-immunized mice, Fas molecules were required. Although DNA-HSP65 or CpG/CFP immunization stimulated antigen-specific production of IFN-γ and IL-10, the effect of DNA-HSP65 was associated with IL-10 while CpG/CFP was associated with IFN-γ. Moreover, after stimulation with mycobacterial antigens plus Der p 1 allergen, cells from mite-allergic patients with asthma exhibited similar patterns of cytokine production as those found in the lung of treated mice. CONCLUSIONS This study provides new insights on the mechanisms of allergen-free immunotherapy by showing that both DNA-HSP65 and CpG/CFP downregulated house dust mite-induced allergic airway inflammation via distinct pathways that involve not only induction of mycobacterial-specific adaptive responses but also signaling via MyD88 and Fas molecules.
Collapse
Affiliation(s)
- D. M. Fonseca
- Department of Biochemistry and Immunology; Ribeirão Preto Medical School; University of São Paulo; Ribeirão Preto Brazil
| | - P. F. Wowk
- Department of Biochemistry and Immunology; Ribeirão Preto Medical School; University of São Paulo; Ribeirão Preto Brazil
- Carlos Chagas Institute; Oswaldo Cruz Foundation; Curitiba Brazil
| | - M. O. Paula
- Department of Biochemistry and Immunology; Ribeirão Preto Medical School; University of São Paulo; Ribeirão Preto Brazil
| | - A. F. Gembre
- Department of Biochemistry and Immunology; Ribeirão Preto Medical School; University of São Paulo; Ribeirão Preto Brazil
| | - M. D. Baruffi
- Department of Clinical Analyses, Toxicology and Food Sciences; Faculty of Pharmaceutical Sciences of Ribeirão Preto; University of São Paulo; Ribeirão Preto Brazil
| | - M. L. Fermino
- Department of Clinical Analyses, Toxicology and Food Sciences; Faculty of Pharmaceutical Sciences of Ribeirão Preto; University of São Paulo; Ribeirão Preto Brazil
| | - W. M. Turato
- Department of Biochemistry and Immunology; Ribeirão Preto Medical School; University of São Paulo; Ribeirão Preto Brazil
| | - L. W. Campos
- Department of Biochemistry and Immunology; Ribeirão Preto Medical School; University of São Paulo; Ribeirão Preto Brazil
| | - C. L. Silva
- Department of Biochemistry and Immunology; Ribeirão Preto Medical School; University of São Paulo; Ribeirão Preto Brazil
| | - S. G. Ramos
- Department of Pathology; Ribeirão Preto Medical School; University of São Paulo; Ribeirão Preto Brazil
| | - C. Horn
- Laboratory of Immunology and Immunogenetics; Evandro Chagas Clinical Research Institute; Oswaldo Cruz Foundation; Rio de Janeiro Brazil
| | - G. Marchal
- Immunotherapix Bio Top; Institute Pasteur; Paris France
| | - L. K. Arruda
- Department of Medicine; Ribeirão Preto Medical School; University of São Paulo; Ribeirão Preto Brazil
| | - M. Russo
- Department of Immunology; Institute of Biomedical Sciences; University of São Paulo; São Paulo Brazil
| | - V. L. D. Bonato
- Department of Biochemistry and Immunology; Ribeirão Preto Medical School; University of São Paulo; Ribeirão Preto Brazil
| |
Collapse
|
4
|
Papain Degrades Tight Junction Proteins of Human Keratinocytes In Vitro and Sensitizes C57BL/6 Mice via the Skin Independent of its Enzymatic Activity or TLR4 Activation. J Invest Dermatol 2015; 135:1790-1800. [PMID: 25705851 DOI: 10.1038/jid.2015.58] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2014] [Revised: 02/06/2015] [Accepted: 02/09/2015] [Indexed: 01/02/2023]
Abstract
Papain is commonly used in food, pharmaceutical, textile, and cosmetic industries and is known to induce occupational allergic asthma. We have previously shown that the papain-like cysteine protease Dermatophagoides pteronyssinus 1 from house dust mite exhibits percutaneous sensitization potential. We aimed here to investigate the potential of papain itself in epicutaneous sensitization. The effects of papain on tight junction (TJ) proteins were tested in vitro in human primary keratinocytes. Using C57BL/6 wild-type and Toll-like receptor 4 (TLR4)-deficient mice, we analyzed the sensitization potential of papain, its effects on the skin barrier, and immune cell recruitment. Our results show that papain affects the skin barrier by increasing transepidermal water loss, degrading TJ proteins and inducing vasodilation. When topically applied, papain exhibited a high epicutaneous inflammatory potential by recruiting neutrophils, mast cells, and CD3-positive cells and by induction of a TH2-biased antibody response. However, its high potency for specific sensitization via the skin was TLR4 independent and, in spite of its capacity to degrade epidermal TJ proteins, does not rely on its enzymatic function. From our data, we conclude that papain has all features to act as a strong allergen via the skin.
Collapse
|
5
|
Newton GK, Perrior TR, Jenkins K, Major MR, Key RE, Stewart MR, Firth-Clark S, Lloyd SM, Zhang J, Francis-Newton NJ, Richardson JP, Chen J, Lai P, Garrod DR, Robinson C. The discovery of potent, selective, and reversible inhibitors of the house dust mite peptidase allergen Der p 1: an innovative approach to the treatment of allergic asthma. J Med Chem 2014; 57:9447-62. [PMID: 25365789 PMCID: PMC4257840 DOI: 10.1021/jm501102h] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
![]()
Blocking
the bioactivity of allergens is conceptually attractive
as a small-molecule therapy for allergic diseases but has not been
attempted previously. Group 1 allergens of house dust mites (HDM)
are meaningful targets in this quest because they are globally prevalent
and clinically important triggers of allergic asthma. Group 1 HDM
allergens are cysteine peptidases whose proteolytic activity triggers
essential steps in the allergy cascade. Using the HDM allergen Der
p 1 as an archetype for structure-based drug discovery, we have identified
a series of novel, reversible inhibitors. Potency and selectivity
were manipulated by optimizing drug interactions with enzyme binding
pockets, while variation of terminal groups conferred the physicochemical
and pharmacokinetic attributes required for inhaled delivery. Studies
in animals challenged with the gamut of HDM allergens showed an attenuation
of allergic responses by targeting just a single component, namely,
Der p 1. Our findings suggest that these inhibitors may be used as
novel therapies for allergic asthma.
Collapse
Affiliation(s)
- Gary K Newton
- Department of Medicinal Chemistry, Domainex Ltd. , 162 Cambridge Science Park, Cambridge CB4 0GH, United Kingdom
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Halim A, Carlsson MC, Madsen CB, Brand S, Møller SR, Olsen CE, Vakhrushev SY, Brimnes J, Wurtzen PA, Ipsen H, Petersen BL, Wandall HH. Glycoproteomic analysis of seven major allergenic proteins reveals novel post-translational modifications. Mol Cell Proteomics 2014; 14:191-204. [PMID: 25389185 DOI: 10.1074/mcp.m114.042614] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Abstract
Allergenic proteins such as grass pollen and house dust mite (HDM) proteins are known to trigger hypersensitivity reactions of the immune system, leading to what is commonly known as allergy. Key allergenic proteins including sequence variants have been identified but characterization of their post-translational modifications (PTMs) is still limited. Here, we present a detailed PTM(1) characterization of a series of the main and clinically relevant allergens used in allergy tests and vaccines. We employ Orbitrap-based mass spectrometry with complementary fragmentation techniques (HCD/ETD) for site-specific PTM characterization by bottom-up analysis. In addition, top-down mass spectrometry is utilized for targeted analysis of individual proteins, revealing hitherto unknown PTMs of HDM allergens. We demonstrate the presence of lysine-linked polyhexose glycans and asparagine-linked N-acetylhexosamine glycans on HDM allergens. Moreover, we identified more complex glycan structures than previously reported on the major grass pollen group 1 and 5 allergens, implicating important roles for carbohydrates in allergen recognition and response by the immune system. The new findings are important for understanding basic disease-causing mechanisms at the cellular level, which ultimately may pave the way for instigating novel approaches for targeted desensitization strategies and improved allergy vaccines.
Collapse
Affiliation(s)
- Adnan Halim
- From the ‡Copenhagen Center for Glycomics and Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark
| | - Michael C Carlsson
- From the ‡Copenhagen Center for Glycomics and Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark
| | - Caroline Benedicte Madsen
- From the ‡Copenhagen Center for Glycomics and Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark
| | | | - Svenning Rune Møller
- From the ‡Copenhagen Center for Glycomics and Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark; ¶Department of Plant and Environmental Biology, Glyco section, Faculty of Science, University of Copenhagen 1871 Frederiksberg C, Denmark
| | - Carl Erik Olsen
- ¶Department of Plant and Environmental Biology, Glyco section, Faculty of Science, University of Copenhagen 1871 Frederiksberg C, Denmark
| | - Sergey Y Vakhrushev
- From the ‡Copenhagen Center for Glycomics and Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark
| | | | | | | | - Bent L Petersen
- From the ‡Copenhagen Center for Glycomics and Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark; ¶Department of Plant and Environmental Biology, Glyco section, Faculty of Science, University of Copenhagen 1871 Frederiksberg C, Denmark
| | - Hans H Wandall
- From the ‡Copenhagen Center for Glycomics and Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, DK-2200 Copenhagen N, Denmark;
| |
Collapse
|
7
|
Lee KE, Han BK, Han JY, Hong JY, Kim MN, Heo WI, Sohn MH, Kim KW, Kim KE. Production of egg yolk antibodies specific to house dust mite proteins. Yonsei Med J 2014; 55:999-1004. [PMID: 24954330 PMCID: PMC4075406 DOI: 10.3349/ymj.2014.55.4.999] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
PURPOSE House dust mites (HDMs) are an important source of indoor allergens associated with asthma, rhinitis and atopic dermatitis. Chicken immunoglobulin (Ig) Y is known to be a good alternative to mice and rabbit antibody production. In this study, we produced IgYs specific to HDMs and investigated their IgE immunoreactivities. MATERIALS AND METHODS Total IgYs were isolated from the yolks of White Leghorn hens immunized with either Dermatophagoides pteronyssinus or D. farinae protein extract. Control antibodies were separated from the yolks of immunized hens with phosphate buffered saline. IgYs specific to HDMs were analyzed using enzyme-linked immunosorbent assay and Western blotting analysis. RESULTS The concentration of egg IgY specific to D. farinae in an immunized hen increased and the highest achieved was 661.3 ug/mg (per an egg) on day 47, compared with 760 ug/mg IgY specific to D. pteronyssinus on day 16. The D. pteronyssinus or D. farinae-specific IgY was detected by binding of each mite proteins, and their immunoreactivities were elevated dependent of the specific IgY concentration. CONCLUSION IgY specific to HDMs may be a promising antibody for immunological diagnosis as well as identification of possible resistance relating to HDM allergy.
Collapse
Affiliation(s)
- Kyung Eun Lee
- Department of Pediatrics and Institute of Allergy, Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
| | | | - Jae Yong Han
- Department of Agricultural Biotechnology, WCU Biomodulation Major, Seoul National University, Seoul, Korea
| | - Jung Yeon Hong
- Department of Pediatrics and Institute of Allergy, Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
| | - Mi Na Kim
- Department of Pediatrics and Institute of Allergy, Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
| | - Won Il Heo
- Department of Pediatrics and Institute of Allergy, Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
| | - Myung Hyun Sohn
- Department of Pediatrics and Institute of Allergy, Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
| | - Kyung Won Kim
- Department of Pediatrics and Institute of Allergy, Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
| | - Kyu Earn Kim
- Department of Pediatrics and Institute of Allergy, Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
| |
Collapse
|
8
|
Abstract
Existing therapies for allergic asthma are far from perfect: the global prevalence of disease increases despite them and they are poorly effective in dealing with the exacerbations that account for hospitalization and asthma deaths. Commercially, there are pressures on these existing medicines too--a growing threat from generics and reluctance by payers to reimburse for increasingly marginal improvements in medicines with precedented mechanisms. Experience shows that attempts to devise selective small-molecule interventions directed at the myriad of downstream effector pathways has not been a fertile ground for the development of effective new medicines. An alternative strategy, exploiting breakthroughs in understanding the molecular basis of allergenicity and the key role of innate immune mechanisms in asthma, is to direct new approaches to the disease triggers themselves: allergens. This raises interesting possibilities for anti-Lipinski drug design (extracellular nonhuman targets, inhaled delivery) and creates unprecedented pharmacological opportunities in the therapeutic area.
Collapse
|
9
|
Abstract
Activation of receptors of the innate immune system is a critical step in the initiation of immune responses. It has been shown that dominant allergens have properties that could allow them to interact with toll-like and C-type lectin receptors to favour Th2-biased responses and many bind lipids and glycans that could associate with ligands to mimic pathogen-associated microbial patterns. In accord with the proposed allergen-specific innate interactions it has been shown that the immune responses to different allergens and antigens from the same source are not necessarily coordinately regulated.
Collapse
Affiliation(s)
- W R Thomas
- Centre for Child Health Research, University of Western Australia, Telethon Institute for Child Health Research, Subiaco, Western Australia, Australia.
| |
Collapse
|
10
|
Henriquez OA, Den Beste K, Hoddeson EK, Parkos CA, Nusrat A, Wise SK. House dust mite allergen Der p 1 effects on sinonasal epithelial tight junctions. Int Forum Allergy Rhinol 2013; 3:630-5. [PMID: 23592402 DOI: 10.1002/alr.21168] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2012] [Revised: 01/29/2013] [Accepted: 02/19/2013] [Indexed: 11/12/2022]
Abstract
BACKGROUND Epithelial permeability is highly dependent upon the integrity of tight junctions, which are cell-cell adhesion complexes located at the apical aspect of the lateral membrane of polarized epithelial cells. We hypothesize that sinonasal epithelial exposure to Der p 1 house dust mite antigen decreases expression of tight junction proteins (TJPs), representing a potential mechanism for increased permeability and presentation of antigens across the sinonasal epithelial layer. METHODS Confluent cultured primary human sinonasal epithelial cells were exposed to recombinant Der p 1 antigen vs control, and transepithelial resistance measurements were performed over 24 hours. Antibody staining for a panel of TJPs was examined with immunofluorescence/confocal microscopy and Western blotting. Tissue for these experiments was obtained from 4 patients total. RESULTS Der p 1 exposed sinonasal cells showed a marked decrease in transepithelial resistance when compared to control cells. In addition, results of Western immunoblot and immunofluorescent labeling demonstrated decreased expression of TJPs claudin-1 and junction adhesion molecule-A (JAM-A) in Der p 1-exposed cultured sinonasal cells vs controls. CONCLUSION Der p 1 antigen exposure decreases sinonasal epithelium TJP expression, most notably seen in JAM-A and claudin-1 in these preliminary experiments. This decreased TJP expression likely contributes to increased epithelial permeability and represents a potential mechanism for transepithelial antigen exposure in allergic rhinitis.
Collapse
|
11
|
Szalai K, Kopp T, Lukschal A, Stremnitzer C, Wallmann J, Starkl P, Vander Elst L, Saint-Remy JM, Pali-Schöll I, Jensen-Jarolim E. Establishing an allergic eczema model employing recombinant house dust mite allergens Der p 1 and Der p 2 in BALB/c mice. Exp Dermatol 2013; 21:842-6. [PMID: 23163649 PMCID: PMC3532600 DOI: 10.1111/exd.12015] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
The major house dust mite allergens Der p 1 and Der p 2 are prevalent inducers of eczema. Der p 1 is a cysteine protease disrupting epithelial barriers, whereas Der p 2 functionally mimics the LPS-binding compound MD-2 within the TLR4 complex. In this work, we tested the percutaneous sensitizing capacity of recombinant (r) Der p 1 and Der p 2 in BALB/c mice. Mice were sensitized by percutaneous application of low (10 μg/application) and high dose (100 μg) rDer p 1 or rDer p 2, or with rDer p 1 followed by rDer p 2. Allergen-specific and total IgE antibodies were determined by ELISA. Eczema of BALB/c was classified by the itching score and corresponded to erosions. Infiltrating immune cells were identified by haematoxylin/eosin and Giemsa staining for eosinophils or mast cells, CD3 staining for T lymphocytes. Percutaneous treatments with rDer p 1, but not rDer p 2-induced specific IgG1. However, cotreatment with rDer p 1 led to increase in anti-Der p 2 IgG titres. Both allergens elicited skin erosions because of scratching, thickening of the epidermis, and eosinophil and T-cell infiltration. Our data indicate that recombinant mite allergens in the absence of adjuvant are sufficient for inducing eczema in BALB/c mice. As the enzymatic activity of an allergen might be an important cofactor for specific sensitization via the skin, Der p 1 may act as adjuvant for other allergens too. The presented mouse model is suitable for investigating the mechanisms of allergic eczema.
Collapse
Affiliation(s)
- Krisztina Szalai
- Comparative Medicine, Messerli Research Institute, University of Veterinary Medicine Vienna, Medical University Vienna, University Vienna, Vienna, Austria
| | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Thomas WR, Hales BJ, Smith WA. House dust mite allergens in asthma and allergy. Trends Mol Med 2010; 16:321-8. [PMID: 20605742 DOI: 10.1016/j.molmed.2010.04.008] [Citation(s) in RCA: 149] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2010] [Revised: 04/15/2010] [Accepted: 04/16/2010] [Indexed: 10/19/2022]
Abstract
IgE antibodies in house dust mite (HDM) allergy follow a predictable pattern. Half are directed against two dominant allergens and the remainder largely against four midpotency allergens. This hierarchical pattern is not changed by the titre of the IgE response or severity of disease. The structures of these allergens are known and they can be produced as authentic recombinant allergens. There is also evidence that the allergenicity is augmented by the biological activity of the key allergens, validating them as targets for vaccination. Collectively, these developments should facilitate the development of new diagnostics, improve immunotherapy and allow vaccination with defined reagents. Highly purified recombinant polypeptides representing the important mite allergens are now available so that informative and reproducible experiments can be performed with mite allergens in place of poorly defined and variable extracts.
Collapse
Affiliation(s)
- Wayne R Thomas
- Centre for Child Health Research, University of Western Australia, Telethon Institute for Child Health Research, Subiaco, Western Australia 6008, Australia.
| | | | | |
Collapse
|